The companies are tapping a longstanding partnership and said they would finalize financial details and terms in the coming weeks. The effort will involve using neutralizing antibodies against SARS-CoV-2 from hundreds of Covid-19 patients.
The immune system is nature’s most finely-tuned diagnostic, so how will we use it to thwart disease and promote health?
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
In a first, the agency approved Adaptive Biotechnologies' clonoSEQ assay to detect MRD in acute lymphoblastic leukemia and multiple myeloma, a measure that can predict risk of relapse.